Factors associated with death by covid-19 in a university hospital in southern Brazil: A cross-sectional study
DOI:
https://doi.org/10.21527/2176-7114.2024.49.14706Keywords:
COVID-19, Epidemiology, Brazil, University Hospitals, MortalityAbstract
This is a cross-sectional study with retrospective data collection that analyzed 356 patients admitted to a university hospital that serves as a reference for severe cases of COVID-19 during the first and second waves in Rio Grande do Sul, Brazil. Mortality was the outcome of interest, and significant variables were subjected to Poisson regression. Ninety-nine patients (27.8%) had death as an outcome. Low education, admission in poor general condition, malnutrition, lack of prior diagnosis of COVID-19, the presence of symptoms other than flu or respiratory symptoms, and polypharmacy were more common in patients who died. Reduced glomerular filtration rate, D-Dimer, C-reactive protein, urea, and elevated International Normalized Ratio were found upon hospital admission in patients who died. No differences were found in deaths between periods of the pandemic. After multivariate analysis, the factors related to death, in decreasing order of prevalence, were institutionalization, prolonged mechanical ventilation (>21 days) or for up to 21 days, high International Normalized Ratio on admission, age over 65 years, need for dialysis, and acute respiratory insufficiency. The results help to understand the behavior of the disease and provide support for training and resource allocation in scenarios of exponential care demands, such as outbreaks and epidemics.
References
Saber-Ayad M, Saleh MA, Abu-Gharbieh E. The rationale for potential pharmacotherapy of COVID-19. Pharmaceuticals. 2020;13(5):1-29. doi:10.3390/ph13050096
Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. The epidemiology , diagnosis and treatment of COVID-19. Int J Antimicrob Agents. 2020;55(January):12 p.
Brasil. Painel de casos de doença pelo coronavírus 2019 (COVID-19) no Brasil pelo Ministério da Saúde. Published 2023. Accessed June 11, 2023. https://covid.saude.gov.br/
Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533-534. doi:10.1016/S1473-3099(20)30120-1
SES/RS. Painel Coronavírus RS. Published 2023. Accessed June 11, 2023. https://ti.saude.rs.gov.br/covid19/
Zeiser FA, Donida B, da Costa CA, et al. First and second COVID-19 waves in Brazil: A cross-sectional study of patients’ characteristics related to hospitalization and in-hospital mortality. Lancet Reg Health - Am. 2021;6:100107. doi:10.1016/j.lana.2021.100107
Hatamabadi H, Sabaghian T, Sadeghi A, et al. Epidemiology of COVID-19 in Tehran, Iran: A Cohort Study of Clinical Profile, Risk Factors, and Outcomes. BioMed Res Int. 2022;2022:2350063. doi:10.1155/2022/2350063
Hallal PC, Victora CG. Overcoming Brazil’s monumental COVID-19 failure: an urgent call to action. Nat Med. 2021;27(6):933-933. doi:10.1038/s41591-021-01353-2
Baqui P, Bica I, Marra V, Ercole A, Schaar M van der. Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study. Lancet Glob Health. 2020;8(8):e1018-e1026. doi:10.1016/S2214-109X(20)30285-0
Ferraretto EK. Nove Meses de Enfrentamento Da COVID-19: Relato de Experiência Do Hospital de Clínicas de Porto Alegre.; 2020.
Vaz, T. A., Avila, A. M., Mancuso, A. C. B., Zini, D. W., Pons, M. T., Borges, R. B. & Camey, S. A. Biobanco COVID-19. Published online 2020. dx.doi.org/10.22491/hcpa-biobanco
Yoshikawa, Gilberto, Castro, Roberto Chaves. Manual de Semiologia Médica: A Prática Do Exame Físico. Universidade do Estado do Pará; 2015.
WHO Consultation on Obesity (1999: Geneva S, Organization WH. Obesity : preventing and managing the global epidemic : report of a WHO consultation. World Health Organization; 2000. Accessed June 11, 2023. https://apps.who.int/iris/handle/10665/42330
Kellum, J. A., Lameire, N., Aspelin, P., Barsoum, R. S., Burdmann, E. A., Goldstein, S. L., Herzog, C. A., Joannidis, M., Kribben, A., Levey, A. S., MacLeod, A. M., Mehta, R. L., Murray, P. T., Naicker, S., Opal, S. M., Schaefer, F., Schetz, M.,; Uchino, S. Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1. doi:10.1038/kisup.2012.1
Associação de Medicina Intensiva GS e, Sociedade Brasileira de Pneumologia e Tisiologia. Diretrizes Brasileiras de Ventilação Mecânica. 2013;39(1). Accessed June 11, 2023. http://www.jornaldepneumologia.com.br/details/3242/pt-BR
AMIB. Recomendações da Associação de Medicina Intensiva Brasileira para a abordagem do COVID-19 em medicina intensiva Abril 2020. Assoc Med Intensiva Bras. Published online 2020:1-77.
Malta M, Cardoso LO, Bastos FI, Magnanini MMF, Silva CMFP da. STROBE initiative: guidelines on reporting observational studies. Rev Saúde Pública. 2010;44:559-565. doi:10.1590/S0034-89102010000300021
Sousa EL de, Gaído SB, Sousa RA de, et al. Profile of hospital admissions and deaths due to severe acute respiratory syndrome caused by COVID-19 in Piauí, Brazil: a descriptive study, 2020-2021. Epidemiol E Serv Saude Rev Sist Unico Saude Bras. 2022;31(1):e2021836. doi:10.1590/S1679-49742022000100009
Deitos J, Lima RBH, Pereira DM, Seki KLM. Perfil epidemiológico e desfecho clínico de pacientes internados com COVID-19 em um Hospital Universitário de Campo Grande – MS. Res Soc Dev. 2022;11(4):e6111427046-e6111427046. doi:10.33448/rsd-v11i4.27046
Escosteguy CC, Eleuterio T de A, Pereira AGL, et al. COVID-19: a cross-sectional study of suspected cases admitted to a federal hospital in Rio de Janeiro, Brazil, and factors associated with hospital death. Epidemiol E Serviços Saúde. 2021;30(1). doi:10.1590/s1679-49742021000100023
Tiwari L, Gupta P, N Y, et al. Clinicodemographic profile and predictors of poor outcome in hospitalised COVID-19 patients: a single-centre, retrospective cohort study from India. BMJ Open. 2022;12(6):e056464. doi:10.1136/bmjopen-2021-056464
Ergenc Z, Ergenc H, Araç S, et al. Predictors of disease severity, clinical course, and therapeutic outcome in COVID-19 patients: our experience with 1,700 patients. Eur Rev Med Pharmacol Sci. 2022;26(21):8180-8187. doi:10.26355/eurrev_202211_30171
Jutzeler CR, Bourguignon L, Weis CV, et al. Comorbidities, Clinical Signs and Symptoms, Laboratory Findings, Imaging Features, Treatment Strategies, and Outcomes in Adult and Pediatric Patients with COVID-19: A Systematic Review and Meta-Analysis. Infectious Diseases (except HIV/AIDS); 2020. doi:10.1101/2020.05.20.20103804
Li Y, Ashcroft T, Chung A, et al. Risk factors for poor outcomes in hospitalised COVID-19 patients: A systematic review and meta-analysis. J Glob Health. 2021;11:10001. doi:10.7189/jogh.11.10001
Sansone NMS, Pereira LR, Boschiero MN, Valencise FE, Fraga AMA, Marson FAL. Characterization of Clinical Features of Hospitalized Patients Due to the SARS-CoV-2 Infection in the Absence of Comorbidities Regarding the Sex: An Epidemiological Study of the First Year of the Pandemic in Brazil. Int J Environ Res Public Health. 2022;19(15):8895. doi:10.3390/ijerph19158895
Silva BRO, Rodrigues WF, Abadia DGP, et al. Clinical-Epidemiology Aspect of Inpatients With Moderate or Severe COVID-19 in a Brazilian Macroregion: Disease and Countermeasures. Front Cell Infect Microbiol. 2022;12:899702. doi:10.3389/fcimb.2022.899702
Mascarello KC, Vieira ACBC, Souza ASS de, Marcarini WD, Barauna VG, Maciel ELN. COVID-19 hospitalization and death and relationship with social determinants of health and morbidities in Espírito Santo State, Brazil: a cross-sectional study. Epidemiol E Serv Saude Rev Sist Unico Saude Bras. 2021;30(3):e2020919. doi:10.1590/S1679-49742021000300004
Pereira RHM, Braga CKV, Servo LM, et al. Geographic access to COVID-19 healthcare in Brazil using a balanced float catchment area approach. Soc Sci Med 1982. 2021;273:113773. doi:10.1016/j.socscimed.2021.113773
Xavier AR, Silva JS, Almeida JPCL, Conceição JFF, Lacerda GS, Kanaan S. COVID-19: manifestações clínicas e laboratoriais na infecção pelo novo coronavírus. J Bras Patol E Med Lab. 2020;56:1-9. doi:10.5935/1676-2444.20200049
Ismail B, Nazri M, Harun A, Ali S, Omar M, Zainy Z. Predictors of polymyxin B treatment failure in Gram-negative healthcare-associated infections among critically ill patients. J Microbiol Immunol Infect. Published online 2017:1-7. doi:10.1016/j.jmii.2017.03.007
Baker J, Krishnan N, Abroms LC, Berg CJ. The Impact of Tobacco Use on COVID-19 Outcomes: A Systematic Review. J Smok Cessat. 2022;2022:5474397. doi:10.1155/2022/5474397
Gray WK, Navaratnam AV, Day J, Wendon J, Briggs TWR. COVID-19 hospital activity and in-hospital mortality during the first and second waves of the pandemic in England: an observational study. Thorax. Published online November 2021:thoraxjnl-2021-218025. doi:10.1136/thoraxjnl-2021-218025
Machado CJ, Pereira CC de A, Viana B de M, et al. Estimativas de impacto da COVID-19 na mortalidade de idosos institucionalizados no Brasil. Ciênc Saúde Coletiva. 2020;25:3437-3444. doi:10.1590/1413-81232020259.14552020
Ho JS, Fernando DI, Chan MY, Sia CH. Obesity in COVID-19: A Systematic Review and Meta-analysis. Ann Acad Med Singapore. 2020;49(12):996-1008. doi:10.47102/annals-acadmedsg.2020299
Houvèssou GM, Leventhal DGP, Silva EV da. Obesity and COVID-19 in-hospital fatality in southern Brazil: impact by age and skin color. Rev Saúde Pública. 2022;56:4. doi:10.11606/s1518-8787.2022056004329
Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet Lond Engl. 2020;395(10239):1763-1770. doi:10.1016/S0140-6736(20)31189-2
Bedock D, Bel Lassen P, Mathian A, et al. Prevalence and severity of malnutrition in hospitalized COVID-19 patients. Clin Nutr Espen. 2020;40:214-219. doi:10.1016/j.clnesp.2020.09.018
Pujolar G, Oliver-Anglès A, Vargas I, Vázquez ML. Changes in Access to Health Services during the COVID-19 Pandemic: A Scoping Review. Int J Environ Res Public Health. 2022;19(3):1749. doi:10.3390/ijerph19031749
Silva VVA da. A COVID-19 enquanto questão social: classe, escolaridade e cor da pandemia no Pará. HOLOS. 2021;1:1-14. doi:10.15628/holos.2021.11519
Marcolino MS, Ziegelmann PK, Souza-Silva MVR, et al. Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: Results from the Brazilian COVID-19 registry. Int J Infect Dis. 2021;107:300-310. doi:10.1016/j.ijid.2021.01.019
Iloanusi S, Mgbere O, Essien EJ. Polypharmacy among COVID-19 patients: A systematic review. J Am Pharm Assoc. 2021;61(5):e14-e25. doi:10.1016/j.japh.2021.05.006
McKeigue PM, Kennedy S, Weir A, et al. Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study. BMC Med. 2021;19(1):51. doi:10.1186/s12916-021-01907-8
Ghasemi H, Darvishi N, Salari N, Hosseinian-Far A, Akbari H, Mohammadi M. Global prevalence of polypharmacy among the COVID-19 patients: a comprehensive systematic review and meta-analysis of observational studies. Trop Med Health. 2022;50:60. doi:10.1186/s41182-022-00456-x
Huang J, Xu Y, Wang B, et al. Risk stratification scores for hospitalization duration and disease progression in moderate and severe patients with COVID-19. BMC Pulm Med. 2021;21(1):120. doi:10.1186/s12890-021-01487-6
Berger JS, Kunichoff D, Adhikari S, et al. Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients with COVID-19. Arterioscler Thromb Vasc Biol. 2020;(October):2539-2547. doi:10.1161/ATVBAHA.120.314872
Ippolito M, Misseri G, Catalisano G, et al. Ventilator-Associated Pneumonia in Patients with COVID-19: A Systematic Review and Meta-Analysis. Antibiot Basel Switz. 2021;10(5):545. doi:10.3390/antibiotics10050545
Campos MR, Schramm JM de A, Emmerick ICM, Rodrigues JM, Avelar FG de, Pimentel TG. Carga de doença da COVID-19 e de suas complicações agudas e crônicas: reflexões sobre a mensuração (DALY) e perspectivas no Sistema Único de Saúde. Cad Saúde Pública. 2020;36(11):e00148920. doi:10.1590/0102-311x00148920
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista Contexto & Saúde
This work is licensed under a Creative Commons Attribution 4.0 International License.
Autores que publicam na Revista Contexto & Saúde concordam com os seguintes termos:
a) A submissão de trabalho(s) científico(s) original(is) pelos autores, na qualidade de titulares do direito de autor do(s) texto(s) enviado(s) ao periódico, nos termos da Lei 9.610/98, implica na cessão de direitos autorais de publicação na Revista Contexto e Saúde do(s) artigo(s) aceitos para publicação à Universidade Regional do Noroeste do Estado do Rio Grande do Sul, autorizando-se, ainda, que o(s) trabalho(s) científico(s) aprovado(s) seja(m) divulgado(s) gratuitamente, sem qualquer tipo de ressarcimento a título de direitos autorais, por meio do site da revista e suas bases de dados de indexação e repositórios, para fins de leitura, impressão e/ou download do arquivo do texto, a partir da data de aceitação para fins de publicação. Isto significa que, ao procederem a submissão do(s) artigo(s) à Revista Contexto e Saúde e, por conseguinte, a cessão gratuita dos direitos autorais relacionados ao trabalho científico enviado, os autores têm plena ciência de que não serão remunerados pela publicação do(s) artigo(s) no periódico.
b). Autores mantém os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a Licença Creative Commons Attribution que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista.
c). Autores têm autorização para assumir contratos adicionais separadamente, para distribuição não-exclusiva da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capítulo de livro), com reconhecimento de autoria e publicação inicial nesta revista.
d). Autores têm permissão e são estimulados a publicar e distribuir seu trabalho online (ex.: em repositórios institucionais ou na sua página pessoal) a qualquer ponto antes ou durante o processo editorial, já que isso pode gerar alterações produtivas, bem como aumentar o impacto e a citação do trabalho publicado (Veja O Efeito do Acesso Livre).